Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Feldman
Darren R
DR
Martorella
Andrew J
AJ
Robbins
Richard J
RJ
Motzer
Robert J
RJ
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000139:chemically induced*; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000097:blood / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects*; D000077210:Sunitinib; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000097:blood
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D013963:Thyroid Hormones; D000077210:Sunitinib